Cytodyn Inc (CYDY)

[Pctwst]

Well, when an argument is lost quickly change to subject to something that can't be verified as truth.

We don't know that to be the case. The US site was last updated 8/9/21. That was a week ago. Since the trials are being done in Brazil, I don't know if there is a delay here or not. Additionally, they are estimated start dates. We will see what happens.

Go to sections
Responsible Party: Hospital Israelita Albert Einstein
ClinicalTrials.gov Identifier: NCT04901676 History of Changes
Other Study ID Numbers: ARO_21_018_001
First Posted: May 25, 2021 Key Record Dates
Last Update Posted: August 9, 2021
Last Verified: May 2021

Study Design
Go to sections
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 612 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Phase 3, Randomized, Double Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Leronlimab in Combination With Standard of Care for Moderately Ill Patients With Coronavirus Disease 2019 (COVID-19) Pneumonia
Estimated Study Start Date : August 9, 2021
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : February 2022